Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expert consensus statement on therapeutic drug monitoring and individualization of linezolid
Bin Lin, Yangmin Hu, Ping Xu, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Kelly A. Cairns, Andrew Udy, Trisha Peel, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 2
Open Access | Times Cited: 37
The Management of Linezolid-Induced Adverse Events in Shorter and Longer Treatment of Rifampicin-Resistant Tuberculosis
Hakob Atshemyan, Naira Khachatryan, Anush Khachatryan, et al.
Annals of Pharmacotherapy (2025)
Closed Access
Linezolid and tedizolid adverse effects: a review on serotonin syndrome, myelosuppression, neuropathies, and lactic acidosis
Adam Greenfield, Erin Deja, Kimberly Lee, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2025) Vol. 5, Iss. 1
Open Access
Therapeutic drug monitoring in the treatment of tuberculosis patients
Diana Ivanova, Н. В. Литвинова, E. I. Yurovskаya, et al.
Tuberkulez i socialʹno značimye zabolevaniâ (2025) Vol. 12, Iss. 4, pp. 54-65
Closed Access
Antibiotic–Drug Interactions in the Intensive Care Unit: A Literature Review
Paweł Radkowski, Maria Derkaczew, Michał Mazuchowski, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 503-503
Open Access | Times Cited: 4
Towards a better detection of patients at-risk of linezolid toxicity in clinical practice: a prospective study in three Belgian hospital centers
Hélène Thirot, David Fage, Antonia Leonhardt, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Linezolid brain penetration in neurointensive care patients
Arthur Hosmann, Miriam M. Moser, Wisse van Os, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 3, pp. 669-677
Open Access | Times Cited: 1
Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study
Peđja Kovačević, Dragana Milaković, Tijana Kovačević, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 10, pp. 7747-7756
Closed Access | Times Cited: 1
Therapeutic Drug Monitoring of Linezolid in Drug-Resistant Tuberculosis Patients: Clinical Factors and Hematological Toxicities
Junjie Cheng, Yuan Yuan, Jinmeng Li, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 2531-2540
Open Access | Times Cited: 1
A nomogram incorporating linezolid and metabolite concentrations for predicting linezolid induced thrombocytopenia in patients with renal impairment
Hanzhen Zhao, Lian Tang, Zhiwei Zhuang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 1
Status and Quality of Guidelines for Therapeutic Drug Monitoring Based on AGREE II Instrument
Zhan‐Miao Yi, Xinya Li, Zhitong Wang, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 9, pp. 1201-1217
Closed Access | Times Cited: 3
Oral Antibiotics for Bacteremia and Infective Endocarditis: Current Evidence and Future Perspectives
Gerasimos Eleftheriotis, Markos Marangos, Maria Lagadinou, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 3004-3004
Open Access | Times Cited: 3
Optimization of Therapy and the Risk of Probiotic Use during Antibiotherapy in Septic Critically Ill Patients: A Narrative Review
Maria Ioana Onofrei, Cristina Mihaela Ghiciuc, Cătălina Luca, et al.
Medicina (2023) Vol. 59, Iss. 3, pp. 478-478
Open Access | Times Cited: 2
Population Pharmacokinetic Model of Linezolid and Probability of Target Attainment in Patients with COVID-19-Associated Acute Respiratory Distress Syndrome on Veno-Venous Extracorporeal Membrane Oxygenation—A Step toward Correct Dosing
Dragana Milaković, Tijana Kovačević, Peđja Kovačević, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 253-253
Open Access
Can linezolid be validly measured in endotracheal aspiration in critically ill patients? A proof-of-concept trial
Diana Rebholz, Uwe Liebchen, Michael Paal, et al.
Intensive Care Medicine Experimental (2024) Vol. 12, Iss. 1
Open Access
Estimation of linezolid exposure in patients with hepatic impairment using machine learning based on a population pharmacokinetic model
Ru Liao, Lihong Chen, Xiaoliang Cheng, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 8, pp. 1241-1251
Closed Access
Evaluation of Pharmacokinetic Pharmacodynamic Target Attainment and Hematological Toxicity of Linezolid in Pediatric Patients
Manal Abouelkheir, Maram R. Aldawsari, Leen Ghonem, et al.
Research Square (Research Square) (2024)
Open Access
Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients
Manal Abouelkheir, Maram R. Aldawsari, Leen Ghonem, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 11, pp. 1807-1817
Open Access
Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review
Laura Gras-Martín, Adrián Plaza‐Díaz, Borja Zarate-Tamames, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 801-801
Open Access
Evaluation and Application of Population Pharmacokinetic Models for Optimising Linezolid Treatment in Non-Adherence Multidrug-Resistant Tuberculosis Patients
Rong Li, Feng Sun, Zhen Feng, et al.
European Journal of Pharmaceutical Sciences (2024), pp. 106915-106915
Open Access
Development of an evaluation system for rational drug use in patients with chronic kidney disease using the Delphi method
Wenjie Yao, Xiaolan Ye, Guobing Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study
Yuki Inoue, Hitoshi Kashiwagi, Yuki Sato, et al.
International Journal of Clinical Pharmacy (2024)
Closed Access
Therapeutic drug monitoring of linezolid in Chinese premature neonates: a population pharmacokinetic analysis and dosage optimization
Lufen Duan, Jingjing Li, Li-rong Shen, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 11
Open Access
Dosificación de fármacos en el paciente obeso crítico, una revisión bibliográfica
Hector Carlos García-Díaz, Pablo Sánchez-Sancho, Pilar Lalueza-Broto, et al.
Farmacia Hospitalaria (2024)
Open Access
Population Pharmacokinetic/Pharmacodynamic Study of Linezolid in Hospital-Acquired Pneumonia Patients with Renal Insufficiency
Jinhui Xu, Xiang-long Chen, Qian Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 5073-5086
Open Access
Page 1 - Next Page

Scroll to top